Adalimumab vs Nivolumab

## Adalimumab vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Nivolumab**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Nivolumab — 27 days.

## Chemical Properties

**Type**: Adalimumab — Antibody; Nivolumab — Antibody.